| Serious Infections among Immunocompromised Health Plan Members | | | 02/24/2021 |
| Cutaneous Small-Vessel Vasculitis following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses | | | 02/04/2021 |
| Direct Oral Anticoagulants (DOACs), Warfarin, Allopurinol, or Propylthiouracil Use in Patients with Cutaneous Small-Vessel Vasculitis: A Descriptive Analysis Exploratory Analyses | | | 02/03/2021 |
| Prevalent and Incident Drug Use in a Pediatric Population: A Descriptive Analysis Exploratory Analyses | acetaminophen with codeine, acyclovir, acyclovir sodium, albuterol, albuterol sulfate, levalbuterol HCL, levalbuterol tartrate, nitazoxanide, nizatidine, oxycodone HCL, sucralfate | | 01/12/2021 |
| Abacavir, Carbamazepine, Clopidogrel, and Phenytoin Use: A Descriptive Analysis Exploratory Analyses | | | 01/04/2021 |
| Incidence of Acute Respiratory Failure (ARF) following Trimethoprim-Sulfamethoxazole (TMP-SMX) Use: A Descriptive Analysis Exploratory Analyses | | | 12/22/2020 |
| Thrombotic Events and Death in Inpatient-Identified COVID-19 Patients Exploratory Analyses | | | 12/21/2020 |
| Thrombotic Events in COVID-19 Patients Not Requiring Hospitalization at the Time of Diagnosis Exploratory Analyses | | | 11/25/2020 |
| Serious Infections following Ustekinumab Use: A Descriptive Analysis Safety Analyses | | | 11/24/2020 |
| Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Safety Analyses | | | 11/17/2020 |
| Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis Safety Analyses | | | 11/17/2020 |
| Counts of Individuals with Gout Using Urate-Lowering Therapy (ULT) and Switching between ULT Products: A Descriptive Analysis Exploratory Analyses | | | 11/12/2020 |
| Incidence of Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Descriptive Analysis Exploratory Analyses | | | 11/10/2020 |
| Mini-Sentinel: Diabetic Ketoacidosis following Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors, Sulfonylureas, Saxagliptin, and Sitagliptin Use: A Descriptive Analysis Safety Analyses | | | 11/09/2020 |
| Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses | | gastrointestinal bleeding , intracranial hemorrhage , major extracranial bleeding , thromboembolic stroke | 10/30/2020 |
| Acute Myocardial Infarction and Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched Analysis Safety Analyses | | | 09/16/2020 |
| Factors Related to the Assignment of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) versus Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) Exploratory Analyses | | | 09/16/2020 |
| Frequency of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) and Estimated Incidence Rates of Post-PTSMA Cardiovascular Outcomes: A Descriptive Analysis Exploratory Analyses | | | 09/16/2020 |
| Wrong Frequency Errors with Low Dose Oral Methotrexate Safety Analyses | | | 09/16/2020 |
| Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis Exploratory Analyses | | | 09/15/2020 |
| Cutaneous Small-Vessel Vasculitis following Direct Oral Anticoagulants (DOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis Exploratory Analyses | | | 09/14/2020 |
| Same Day Seizures following Gadolinium Based Contrast Agents: A Self-Controlled Risk Interval Analysis Safety Analyses | | | 09/11/2020 |
| Ranitidine Drug Utilization Patterns Exploratory Analyses | | | 09/03/2020 |
| Intravenous (IV) Iron Utilization Among Pregnant Women Exploratory Analyses | | | 09/02/2020 |
| Algorithms to Estimate Start of Pregnancy Using In-Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and Select Prenatal Tests among Pregnancies Resulting in a Live-Born Delivery Exploratory Analyses | | | 08/28/2020 |
| Mini-Sentinel: Availability of International Normalized Ratio (INR) Laboratory Test Values and INR Test Procedures among New Warfarin Users Exploratory Analyses | | | 08/27/2020 |
| Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF) Exploratory Analyses | | | 08/26/2020 |
| Sacubitril/Valsartan, Angiotensin-Converting Enzyme (ACE) Inhibitors, and Other Angiotensin II Receptor Blockers (ARBs) Use in Patients with Heart Failure Exploratory Analyses | | | 08/26/2020 |
| Mini-Sentinel: Switching Between Generic and Brand Clonazepam Exploratory Analyses | | | 08/25/2020 |
| Glaucoma, Cataracts, Diminished Visual Acuity, and Nasal Septal Perforation following Mometasone Sinus Implant Use in Patients with Nasal Polyposis: A Descriptive Analysis Safety Analyses | | | 08/05/2020 |
| Hypertension in Pediatric Patients: A Descriptive Analysis Exploratory Analyses | | | 07/23/2020 |
| Use of Typical and Atypical Antipsychotics Among Infants Exploratory Analyses | | | 05/20/2020 |
| Characterization of SGLT-2 Inhibitor Users in the Patient-Centered Clinical Research Network (PCORnet) Exploratory Analyses | | | 03/19/2020 |
| Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis Safety Analyses | | | 03/05/2020 |
| Total Enrollment with Medical and Drug Coverage Exploratory Analyses | | | 02/19/2020 |
| Trends in Penicillin Allergy Testing Exploratory Analyses | | | 01/30/2020 |
| Prenatal Tests in Women with Potential Stillbirths Exploratory Analyses | | | 01/24/2020 |
| Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin Exploratory Analyses | | | 01/24/2020 |
| Time Until Guillain-Barré Syndrome or Bell's Palsy Diagnosis following Initiation of Checkpoint Inhibitor Treatment Exploratory Analyses | | | 01/24/2020 |
| Duration of Follow-up for Individuals with Chronic Conditions Exploratory Analyses | | Alzheimer's disease , acquired hypothyroidism , acute myocardial infarction (AMI) , anemia , asthma , atrial fibrillation , benign prostatic hyperplasia , breast cancer , bronchiectasis , chronic conditions , chronic kidney disease (CKD) , chronic obstructive pulmonary disease , colorectal cancer , depression , diabetes , endometrial cancer , glaucoma , heart failure , hyperlipidemia , hypertension , ischemic heart disease , lung cancer , osteoarthritis , osteoporosis , prostate cancer , rheumatoid arthritis , stroke , transient ischemic attack (TIA) | 01/23/2020 |
| Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 Diabetes Exploratory Analyses | | | 01/13/2020 |
| Hydroxyurea Use in Patients with Sickle Cell Anemia Exploratory Analyses | | | 01/07/2020 |
| Mini-Sentinel: Summary of Antidiabetic Agent Use During Pregnancy Exploratory Analyses | dipeptidyl peptidase-4 (DPP-4) inhibitor, sulfonylurea, thiazolidinedione, alpha-glucosidase inhibitor, amylin analog, biguanide, glucagon-like peptide-1 (GLP-1) receptor agonist, meglitinide analog, injectable insulin | | 01/02/2020 |
| Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System Exploratory Analyses | | | 12/06/2019 |
| Estimating Optimal Quantities for Initial Opioid Analgesic Prescriptions for Acute Pain Conditions Presenting to Surgical Settings Exploratory Analyses | | | 11/20/2019 |
| Respiratory Syncytial Virus in a Pediatric Population Exploratory Analyses | | | 11/19/2019 |
| Hydroxyprogesterone Caproate and Progesterone Use During Pregnancy Exploratory Analyses | | | 10/29/2019 |
| Neuropsychiatric Events Following Montelukast Use: A Propensity Score Matched Analysis Safety Analyses | | | 09/27/2019 |
| Multiple Sclerosis Relapses among Copaxone, Glatopa, Gilenya, and Glatiramer Users Exploratory Analyses | | | 09/17/2019 |
| Cutaneous Small Vessel Vasculitis and Acute Kidney Injury Following Direct-Acting Oral Anticoagulant Use Exploratory Analyses | | | 09/16/2019 |
| Non-Melanoma Skin Cancer following Hydrochlorothiazide Use Exploratory Analyses | | | 09/12/2019 |
| Sinus Stents with Mometasone and Diminished Visual Acuity Safety Analyses | | | 09/12/2019 |
| Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric Population Exploratory Analyses | | | 08/22/2019 |
| Utilization Patterns of Qsymia (Phentermine/Topiramate) Exploratory Analyses | | | 08/07/2019 |
| Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics Exploratory Analyses | opioid analgesic, transdermal opioid analgesic, transmucosal opioid analgesic, oral opioid analgesic, lower dosage strength opioid analgesic, higher dosage strength opioid analgesic | | 07/31/2019 |
| Ischemic Stroke, Intracranial Hemorrhage, and Gastrointestinal Hemorrhage Among New Users of Apixaban and Warfarin Exploratory Analyses | | | 07/10/2019 |
| Osteoporotic Fractures Following Lupron Depot-PED Use: A Multiple Factor Matched Analysis Safety Analyses | | | 07/02/2019 |
| Use of Korlym and Mifeprex (Mifepristone) Exploratory Analyses | | | 06/24/2019 |
| Antiemetic Use During Pregnancy Exploratory Analyses | metoclopramide HCL, ondansetron, doxylamine, succinate/pyridoxine HCl, granisetron, netupitant/palonosetron HCl, palonosetron, prochlorperazine, promethazine HCl | | 06/24/2019 |
| Use of Valsartan, Angiotensin II Receptor Blockers (ARB), and Angiotensin-Converting Enzyme (ACE) Inhibitors Exploratory Analyses | valsartan, angiotensin-converting enzyme (ACE) inhibitor, angiotensin II receptor blocker (ARB), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, azilsartan medoxomil | | 06/05/2019 |
| New Users of Oral Bisphosphonates Exploratory Analyses | | | 05/08/2019 |
| Neuropsychiatric Events following Montelukast Use Exploratory Analyses | | | 04/22/2019 |
| Duration of Use Among New Users of Hydrochlorothiazide (HCTZ), Angiotensin-Converting Enzyme Inhibitors (ACEIs), and Angiotensin II Receptor Blockers (ARBs) Exploratory Analyses | | | 04/19/2019 |
| Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Propensity Score Analysis Safety Analyses | | | 04/18/2019 |
| Lupron Depot-PED Use Among Patients with Central Precocious Puberty Exploratory Analyses | | | 04/15/2019 |
| Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Safety Analyses | | | 04/04/2019 |
| Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs Exploratory Analyses | | | 04/02/2019 |
| Dolutegravir Use During Pregnancy Exploratory Analyses | | | 03/28/2019 |
| Acute Myocardial Infarction and Stroke Among Patients with Testosterone-Related Indications Exploratory Analyses | | | 03/25/2019 |
| Brintellix and Brilinta Medication Errors due to Name Confusion Exploratory Analyses | | | 03/24/2019 |
| Characteristics of Gout Patients and Use of Urate-Lowering Therapies Safety Analyses | | | 03/22/2019 |
| Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage Following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis Safety Analyses | | | 02/15/2019 |
| Optimal Initial Length of Opioid Prescription Exploratory Analyses | | | 02/01/2019 |
| Seizure Following Ranolazine Use Safety Analyses | | | 01/03/2019 |
| Use of Multiple Sclerosis Drugs Among Pregnant Women Exploratory Analyses | dimethyl fumarate, dalfampridine, fingolimod, glatiramer acetate, interferon beta-1A, interferon beta-1A/albumin, interferon beta-1B, peginterferon beta-1a, teriflunomide, alemtuzumab, natalizumab, daclizumab, mitoxantrone | | 12/06/2018 |
| Pulmonary Arterial Hypertension and Interstitial Lung Disease Events Among Interleukin Inhibitor Users Exploratory Analyses | | | 12/03/2018 |
| Duration of Use for Teriparatide Exploratory Analyses | | | 11/29/2018 |
| Quantifying Prevalence and Mortality Associated with Neonatal Enteroviral Sepsis (NES) Using Inpatient Data in FDA’s Sentinel System Exploratory Analyses | | | 11/27/2018 |
| COPD, Asthma, and Respiratory Disease Effectiveness (CARE) For 21st Century Cures: Feasibility Assessments for Comparative Effectiveness Studies Exploratory Analyses | | | 11/06/2018 |
| Counts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid Tolerance Exploratory Analyses | | | 11/06/2018 |
| Phosphodiesterase Type 5 (PDE-5) Inhibitor Utilization Among Women Exploratory Analyses | | | 10/12/2018 |
| Sofosbuvir and Amiodarone Use and Bradycardia or Pacemaker Insertion Exploratory Analyses | | | 08/29/2018 |
| Algorithms Evaluating Dabigatran Use and Acute Myocardial Infarction Compared with Warfarin Exploratory Analyses | | | 08/23/2018 |
| Use of Dabigatran and Intracranial Hemorrhage, Gastrointestinal Hemorrhage, Ischemic Stroke, and Acute Myocardial Infarction Safety Analyses | | acute myocardial infarction (AMI) , gastrointestinal hemorrhage , intracranial hemorrhage , ischemic stroke | 08/17/2018 |
| New Pediatric Users of Leuprolide Acetate Depot Exploratory Analyses | | | 08/17/2018 |
| Prevalence and Incidence of Progressive Multifocal Leukoencephalopathy (PML), Clostridium Difficile, and Cytomegalovirus (CMV) Diagnoses Exploratory Analyses | | clostridium difficile , cytomegalovirus (CMV) , progressive multifocal leukoencephalopathy (PML) | 06/04/2018 |
| Incident Use of Selective Serotonin Reuptake Inhibitor Antidepressants Exploratory Analyses | | | 05/21/2018 |
| Identifying Suicide Codes in the Sentinel Distributed Database (SDD) Exploratory Analyses | | | 04/24/2018 |
| Clostridium difficile Infection Following Use of Vancomycin, Fidaxomicin, or Metronidzaole Exploratory Analyses | | | 04/03/2018 |
| Availability of International Normalized Ratio (INR) Laboratory Test Values and Test Procedures Among Warfarin Users Exploratory Analyses | | | 04/03/2018 |
| Warfarin Use Followed by International Normalized Ratio (INR) Lab Codes Exploratory Analyses | | | 04/02/2018 |
| Top Ten Causes of Death Exploratory Analyses | | | 03/29/2018 |
| Prevalent and Incident Use of Fingolimod Exploratory Analyses | | | 03/28/2018 |
| Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users Exploratory Analyses | | | 03/27/2018 |
| Use of Clonazepam Exploratory Analyses | | | 03/26/2018 |
| Prevalence and Incident Use of Promethazine Exploratory Analyses | | | 03/26/2018 |
| Diagnosis of Agranulocytosis Following New Use of Anti-epileptic Drugs, Clozapine, and Olanzapine Exploratory Analyses | | | 03/21/2018 |
| Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Exploratory Analyses | ibandronate sodium, denosumab, alendronate sodium, alendronate sodium/vitamin d3, risedronate sodium/calcium carbonate, risedronate sodium, zoledronic acid, zoledronic acid/mannitol and water, raloxifene HCL, calcitonin, salmon, synthetic, bandronate sodium, calcitonin salmon, teriparatide, zoledroniccid zometa, zoledroniccid reclast, zoledronic acid reclast | | 03/19/2018 |
| Counts and Prevalence of Linezolid and Vancomycin Exploratory Analyses | | | 03/19/2018 |
| Use of Atrial Fibrillation Drugs Exploratory Analyses | | | 03/16/2018 |
| Incident Use of Hepatitis C Virus (HCV) Drugs Exploratory Analyses | | | 03/13/2018 |
| Concomitancy and Indications for Idelalisib Use Exploratory Analyses | bendamustine, bortezomib, chlorambucil, cyclophosphamide, doxorubicin, ibrutinib, idelalisib, lenalidomide, obinutuzumab, ofatumumab, prednisone, rituximab, vincristine, ibritumomab | | 03/13/2018 |
| Prevalent and Incident Use of Generic Name Kinase Inhibitors Exploratory Analyses | afatinib dimaleate, axitinib, cabozantinib s-malate, ceritinib, dabrafenib mesylate, erlotinib HCL, gefitinib, lapatinib ditosylate, pazopanib HCL, sorafenib tosylate, sunitinib malate, vandetanib, bortezomib, carfilzomib, dasatinib, everolimus, ibrutinib, idelalisib, imatinib mesylate, nilotinib HCL, ruxolitinib phosphate, trametinib dimethyl sulfoxide, vemurafenib, crizotinib, ponatinib HCL, regorafenib | | 03/08/2018 |
| Incident Use of Rivaroxaban Exploratory Analyses | | | 03/07/2018 |
| Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Exploratory Analyses | dronedarone, norfloxacin, erythromycin, trimethoprim-sulfamethoxazole, clarithromycin, telithromycin, paroxetine, fluoxetine, duloxetine, amiodarone, dofetilide, flecainide, propafenone, sotalol, azithromycin, amoxicillin, amoxicillin with clavulanate, ciprofloxacin, levofloxacin, clindamycin, cephalexin, penicillin V, gemifloxacin, moxifloxacin, ofloxacin, citalopram, escitalopram, fluvoxamine, sertraline, vilazodone, desvenlafaxine, venlafaxine, levomilnacipran, nefazodone, trazodone, vortioxetine, amitriptyline, amoxapine, doxepin, imipramine, nortriptyline, desipramine, protriptyline, clomipramine, trimipramine, mirtazapine, maprotiline | | 03/06/2018 |
| Drug Utilization Over Time for Three Drug Classes Exploratory Analyses | | | 03/05/2018 |
| Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Safety Analyses | | | 03/04/2018 |
| Venous Thromboembolism Following Continuous or Extended Cycle Contraceptive Use: A Propensity Score Matched Analysis Safety Analyses | | | 03/04/2018 |
| Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products Exploratory Analyses | | | 03/02/2018 |
| Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Safety Analyses | | | 03/02/2018 |
| Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Exploratory Analyses | | | 03/01/2018 |
| Use of Tyrosine Kinase Inhibitors (TKIs) Exploratory Analyses | | | 02/28/2018 |
| Length of Follow-up Time for New Users of Immunosuppressive Drugs Exploratory Analyses | adalimumab, certolizumab, dalfampridine, dimethyl fumarate, etanercept, glatiramer acetate, golimumab, infliximab, interferon beta-1A, interferon beta-1B, natalizumab, teriflunomide, ustekinumab, alemtuzumab, fingolimod, mitoxantrone, pegylated interferon beta-1A | | 02/28/2018 |
| Prevalent and Incident Dispensings of Ranolazine Safety Analyses | | | 02/26/2018 |
| Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use Exploratory Analyses | | | 02/05/2018 |
| Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Safety Analyses | | | 02/01/2018 |
| Prevalent and Incident Use of SGLT2 Inhibitors Exploratory Analyses | canagliflozin, dapagliflozin propanediol, empagliflozin, canagliflozin/metformin HCl, dapagliflozin/metformin HCl, empagliflozin/linagliptin | | 02/01/2018 |
| Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers Safety Analyses | | | 02/01/2018 |
| Antiepileptic Drug (AED) Injection Procedure Codes Exploratory Analyses | | | 01/31/2018 |
| PROMPT: Rivaroxaban Surveillance Safety Analyses | | | 01/31/2018 |
| Counts of Commonly Used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers Exploratory Analyses | | | 01/29/2018 |
| Drug and Medical Enrollment Counts Exploratory Analyses | | | 01/29/2018 |
| Use of Tumor Necrosis Factor (TNF) Blocker Drugs Exploratory Analyses | | | 01/26/2018 |
| A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Safety Analyses | | | 01/26/2018 |
| Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Exploratory Analyses | | | 01/25/2018 |
| Molecularly Targeted Anti-Cancer Therapies Exploratory Analyses | bicalutamide, tamoxifen citrate, everolimus, axitinib, crizoatinib, dasatinib, erlotinib HCL, gefitinib, imatinib mesylate, lapatinib ditosylate, nilotinib HCL, pazopanib HCL, ruxolitinib phosphate, sorafenib tosylate, sunitinib malate, vandetanib, vemurafenib, vismodegib | | 01/24/2018 |
| Stroke Diagnosis Codes Exploratory Analyses | | | 01/18/2018 |
| Length of Enrollment in Pediatric Population Exploratory Analyses | | | 01/17/2018 |
| Prevalent and Incident Use of Isotretinoin Exploratory Analyses | | | 01/16/2018 |
| Occurrence of Selected Generic Drugs 13 Exploratory Analyses | efalizumab, leflunomide, propylthiouracil, rosiglitazone maleate, lamotrigine, metoclopramide HCL, quinine, quinine sulfate, varenicline tartrate, sibutramine HCL m-hydrate, amlodipine besylate, ibandronate sodium, maraviroc, ramipril, tadalafil, nitrofurantoin, nitrofurantoin macrocrystal, nitrofurantoin monohyd/m-crystal | | 01/11/2018 |
| Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Exploratory Analyses | | | 01/08/2018 |
| Use of Dronedarone HCL Exploratory Analyses | | | 01/08/2018 |
| Incident and Prevalent Dispensings of Mirabegron Exploratory Analyses | | | 01/01/2018 |
| Use of Ospemifene, Boceprevir, and Telaprevir Exploratory Analyses | | | 12/29/2017 |
| Prevalent and Incident Use of Testosterone Products Exploratory Analyses | | | 12/21/2017 |
| Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Exploratory Analyses | | | 12/21/2017 |
| Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Exploratory Analyses | | | 12/20/2017 |
| Prevalent and Incident Use of Romiplostim Exploratory Analyses | | | 12/18/2017 |
| Suicide Diagnoses Exploratory Analyses | | | 12/15/2017 |
| Incident and Prevalent Use of Generic Drugs for Overactive Bladder Exploratory Analyses | solifenacin succinate, darifenacin hydrobromide, fesoterodine fumarate, oxybutynin chloride, tolterodine tartrate, trospium chloride | | 12/11/2017 |
| Use of Cancer Drugs Exploratory Analyses | | | 12/08/2017 |
| Antipsychotic Use and Dementia Diagnoses Exploratory Analyses | | | 12/07/2017 |
| Genetic Testing Procedures Exploratory Analyses | | | 12/05/2017 |
| Atrial Fibrillation Prevalence Exploratory Analyses | | | 12/04/2017 |
| Mycophenolate Dispensings and Procedures Exploratory Analyses | | | 12/01/2017 |
| Mycophenolate Dispensings and Procedures (by Quarter) Exploratory Analyses | | | 12/01/2017 |
| Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Safety Analyses | | | 11/06/2017 |
| Stroke Following Typical or Atypical Antipsychotic Use in Non-Elderly Patients: A Propensity Score Matched Analysis Exploratory Analyses | | | 11/02/2017 |
| Stroke Following Atypical Antipsychotic or Z-Hypnotic Use in Patients with Prior Use of Selective Serotonin Reuptake Inhibitors (SSRIs): A Propensity Score Matched Analysis Exploratory Analyses | | | 11/02/2017 |
| Antipsychotics and Stroke Exploratory Analyses | olanzapine, quetiapine, risperidone, aripiprazole, typical antipsychotic, atypical antipsychotic, haloperidol, olanzapine/fluoxetine, selective serotonin reuptake inhibitor (SSRI) | | 11/01/2017 |
| Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification Exploratory Analyses | | | 10/30/2017 |
| Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products Exploratory Analyses | | | 10/12/2017 |
| Alosetron Use Exploratory Analyses | | | 10/11/2017 |
| Mirabegron Use Exploratory Analyses | | | 10/11/2017 |
| Pegylated Products Use Exploratory Analyses | | | 10/06/2017 |
| Pegylated Products Follow-Up Request Exploratory Analyses | | | 10/06/2017 |
| New Molecular Entities Exploratory Analyses | alcaftadine, alglucosidase alfa, cabazitaxel, carglumic acid, ceftaroline fosamil acetate, collagenase clostridium histolyticum, dabigatran etexilate mesylate, dalfampridine, denosumab, eribulin mesylate, estradiol valerate/dienogest, fingolimod HCL, incobotulinumtoxina, liraglutide, lurasidone HCL, pegloticase, polidocanol, tesamorelin acetate, tocilizumab, ulipristal acetate, velaglucerase alfa, boceprevir, clobazam, ezogabine, rivaroxaban, tenofovir disoproxil fumarate, tofacitinib citrate, abiraterone acetate, ziv-aflibercept, avanafil, asparaginase, azilsartan medoxomil, belatacept, belimumab, deferiprone, fidaxomicin, gabapentin enacarbil, gadobutrol, icatibant acetate, indacterol maleate, ioflupane i-123, ipilimumab, linagliptin, rilpivirine HCL, roflumilast, ruxolitinib phosphate, spinosad, telaprevir, ticagrelor, vandetanib, vemurafenib, vilazodone HCL, aclidinium bromide, apixaban, axitinib, bedaquiline fumarate, bosutinib, cabozantinib, carfilzomib, crofelemer, cobicistat, elvitegravir, enzalutamide, florbetapir f-18, glucarpidase, ingenol mebutate, ivacaftor, linaclotide, lomitapide mesylate, lorcaserin HCl, lucinactant, ocriplasmin, omacetaxine mepesuccinate, pasireotide diaspartate, teduglutide, teriflunomide, vismodegib, ado-trastuzumab emtansine, afatinib dimaleate, albiglutide, alogliptin benzoate, apremilast, belinostat, blinatumomab, canagliflozin, ceftolozane, tazobactam, ceritinib, dabrafenib mesylate, dalbavancin HCL, dapagliflozin propanediol, dimethyl fumarate, dolutegravir sodium, droxidopa, dulaglutide, efinaconazole, eliglustat tartrate, elosulfase alfa, empagliflozin, eslicarbazepine acetate, estrogen, bazedoxifene, flutemetamol f-18, fluconazole, vilanterol, gadoterate meglumine, ibrutinib, idelalisib, ledipasvir, luliconazole, macitentan, metreleptin, miltefosine, mipomersen sodium, naloxegol oxalate, netupitant, palonosetron HCL, nintedanib esylate, nivolumab, obinutuzumab, olaparib, olodaterol HCL, ombitasvir, paritaprevir, oritavancin diphosphate, ospemifene, peginterferon beta-1a, pembrolizumab, peramivir, pirfenidone, pomalidomide, radium-223 dichloride, ramucirumab, riociguat, siltuximab, simeprevir sodium, sofosbuvir, sulfur hexafluoride microsphere, suvorexant, tasimelteon, pitavastatin, tedizolid phosphate, trametinib dimethyl sulfoxide, umeclidinium, vedolizumab, vorapaxar sulfate, vortioxetine hydrobromide, alectinib HCL, alirocumab, aripiprazole, aripiprazole lauroxil, asfotase alfa, brexpiprazole, cangrelor tetrasodium, cariprazine HCL, ceftazidime/avibactam, cholic acid, cobimetinib fumarate, daclatasvir dihydrochloride, daratumumab, deoxycholic acid, dinutuximab, edoxaban tosylate, elotuzumab, eluxadoline, elvitegravir/cobicistat/emtricitabine/tenofovir, evolocumab, flibanserin, idarucizumab, insulin degludec, isavuconazonium sulfate, ivabradine HCL, ixazomib citrate, lenvatinib mesylate, lumacaftor/ivacaftor, mepolizumab, necitumumab, osimertinib mesylate, palbociclib, panobinostat lactate, parathyroid hormone, patiromer calcium sorbitex, rolapitant HCL, sacubitril/valsartan, sebelipase alfa, secukinumab, selexipag, sonidegib phosphate, sugammadex sodium, trabectedin, trifluridine/tipiracil HCL, uridine | | 10/04/2017 |
| Indications of Use Among Oral Antifungal Drug Users Exploratory Analyses | | | 09/01/2017 |
| Actemra (Tocilizumab) Utilization Among Pregnant Women Exploratory Analyses | | | 07/18/2017 |
| Anti-epileptic Drugs and Angioedema Exploratory Analyses | | | 07/17/2017 |
| Multiple Births and Preterm Deliveries Exploratory Analyses | | | 05/10/2017 |
| Drug Use Following Genetic Testing Among Patients with Cancer Exploratory Analyses | KRAS, BRAF, estimated glomerular filtration rate (eGFR), BCR-ABL, BRCA, cobimetinib fumarate, trametinib dimethyl sulfoxide, dabrafenib mesylate, vemurafenib, afatinib dimaleate, gefitinib, osimertinib mesylate, erlotinib HCL, bosutinib, imatinib mesylate, ponatinib HCL, dasatinib, nilotinib HCL, olaparib, cetuximab, panitumumab | | 05/10/2017 |
| Influenza Antiviral Drug Use 2010-2015 Exploratory Analyses | | | 05/02/2017 |
| Prevalent Dispensings of Ticagrelor (Brilinta) and Vortioxetine Hydrobromide (Brintellix) Exploratory Analyses | | | 04/23/2017 |
| Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure Exploratory Analyses | | | 10/25/2016 |
| PROMPT: Mirabegron Surveillance Exploratory Analyses | | | 09/21/2016 |
| Dronedarone and Electrocardiograms Exploratory Analyses | | | 08/16/2016 |
| Parenteral Iron and Anaphylactoid Reactions Safety Analyses | | | 07/22/2016 |
| MRI and GBCA Procedures Exploratory Analyses | | | 07/21/2016 |
| Hysterectomy Procedures Among Females Exploratory Analyses | | | 07/21/2016 |
| Most Frequent Generic Dispensings Among Members Aged 65+ Exploratory Analyses | | | 07/21/2016 |
| Dabigatran and Warfarin Use Among Members with Atrial Fibrillation and Other Pre-Existing Conditions Exploratory Analyses | | | 07/21/2016 |
| Incident Testosterone Indication Diagnoses and Testosterone Use Exploratory Analyses | | | 07/06/2016 |
| Hypogonadism and Testosterone Use Exploratory Analyses | | | 07/06/2016 |
| Incident Testosterone Use Exploratory Analyses | | | 07/06/2016 |
| Immunoglobulin Products and Hemolysis Exploratory Analyses | | | 07/06/2016 |
| New Use of Statins and Rhabdomyolysis Exploratory Analyses | | | 06/30/2016 |
| Epidural Steroid Use Exploratory Analyses | | | 06/30/2016 |
| Serum Creatinine Procedures and Labs Exploratory Analyses | | | 06/30/2016 |
| Isotretinoin and Long-term Antibiotic Use and Multiple Sclerosis Exploratory Analyses | | | 06/30/2016 |
| Omalizumab or Montelukast Use Among Individuals with Asthma and Acute Myocardial Infarction, Stroke, Intracranial Hemorrhage, or Pulmonary Embolism Exploratory Analyses | | | 06/21/2016 |
| Laparoscopic Hysterectomy With and Without Robotic Assistance and Adverse Outcomes Exploratory Analyses | | | 06/21/2016 |
| New Use of Dabigatran or Warfarin and Gastrointestinal Hemorrhage or Intracerebral Hemorrhage Events Exploratory Analyses | | | 06/21/2016 |
| New Use of Anti-Epileptic Drugs and Agranulocytosis Exploratory Analyses | | | 06/21/2016 |
| IVIg Product Use and Hemolysis Events Exploratory Analyses | | | 06/03/2016 |
| Incident Use of Testosterone Products Among All Members and Members with Pre-Existing Testosterone Use Exploratory Analyses | Androgel, testosterone cypionate, Axiron, Fortesta, Testim, Striant, methyltestosterone, testosterone, testosterone suspension, testosterone enanthate, testosterone propionate, testosterone pellet, intramuscular testosterone, transdermal testosterone | | 06/03/2016 |
| Concomitant Use of Niacin and Statins and Concomitant Use of Fenofibrates and Statins Exploratory Analyses | | | 06/03/2016 |
| Anticoagulant Use Among Members with Atrial Fibrillation and Various Pre-Existing Exlusions Exploratory Analyses | | | 05/27/2016 |
| Anticoagulant Use Among Members with Pre-Existing Atrial Fibrillation and Various Pre-Existing Exclusions Exploratory Analyses | | | 05/25/2016 |
| Antidepressant Use and Bleeding Events Exploratory Analyses | antidepressant, selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic | | 05/20/2016 |
| Dabigatran Uptake and Persistence Exploratory Analyses | | | 05/20/2016 |
| Incident Antipsychotic Use Exploratory Analyses | aripiprazole, olanzapine, quetiapine, risperidone, antipsychotic, asenapine, clozapine, iloperidone, lurasidone, paliperidone, ziprasidone | | 05/20/2016 |
| Indications of Intravenous Immunoglobulin Use Exploratory Analyses | | | 05/20/2016 |
| Anticoagulants and Bleeding Events Exploratory Analyses | | | 05/20/2016 |
| Anticoagulant Use Among Patients with Atrial Fibrillation Exploratory Analyses | | | 01/31/2016 |
| Drug Use Among Pregnant Women with Live Births Exploratory Analyses | methotrexate, valproic acid, ribavirin, simvastatin, lisinopril, mycophenolate mofetil, paroxetine, sodium valproate, selective serotonin reuptake inhibitor (SSRI), statin, anticonvulsant, angiotensin-converting enzyme (ACE) inhibitor, warfarin, dabigatran | | 01/30/2016 |
| Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart Failure Safety Analyses | anti-diabetic agent (ADA), hypoglycemic drug, dipeptidyl peptidase-4 (DPP-4) inhibitor, sulfonylurea, thiazolidinedione, saxagliptin, sitagliptin, pioglitazone, glimepiride, glipizide, glyburide, long-acting insulin | | 01/26/2016 |
| Select Bisphosphonates and Select Outcomes of Interest Exploratory Analyses | | esophageal cancer , fracture , hip fracture , non-vertebral fracture , osteonecrosis of the jaw | 03/14/2015 |
| Anaphylaxis Events Following Incident Vaccine Exposure Among Members with a Pre-Existing Condition of Milk Allergy Exploratory Analyses | diphtheria, tetanus, acellular pertussis (DTaP) vaccine, diphtheria, tetanus, acellular pertussis (DTaP)-hepatitis B (Hep B)-inactivated polio vaccine (IPV), diphtheria, tetanus, acellular pertussis (DTaP)-haemophilus influenzae type B (HIB) vaccine, diphtheria, tetanus, acellular pertussis (DTaP)-haemophilus influenzae type B (HIB)-inactivated polio vaccine (IPV), diphtheria, tetanus, acellular pertussis (DTaP)-inactivated polio vaccine (IPV), tetanus, diphtheria, pertussis (Tdap) vaccine | | 03/03/2015 |
| Gastrointestinal Disorders Exploratory Analyses | | entercolitis , gastrointestinal disorder , ileocolitis , procitis , proctosigmoiditis , pseudopolyposis , regional enteritis , ulcerative colitis | 02/25/2015 |
| Injection Omalizumab Procedure Codes Exploratory Analyses | | | 02/25/2015 |
| Omalizumab Use Exploratory Analyses | | | 02/25/2015 |
| Prevalent and Incident Use of Pramipexole Exploratory Analyses | | | 02/25/2015 |
| Hypoglycemic Events Following Use of Anti-Diabetic Agents (ADAs) Exploratory Analyses | anti-diabetic agent (ADA), chlorpropamide, glimepiride, glipizide, glyburide, metformin, tolazamide, pioglitazone, rosiglitazone maleate, insulin, glipizide/metformin, glyburide/metformin, pioglitazone/metformin, rosiglitazone/metformin | | 02/25/2015 |
| Omalizumab and Montelukast Use Exploratory Analyses | | | 02/25/2015 |
| Progressive Multifocal Leukoencephalapathy Exploratory Analyses | | | 02/24/2015 |
| Methotrexate and Tofacitinib Use Exploratory Analyses | | | 11/24/2014 |
| Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone Exploratory Analyses | alvimopan, methylnaltrexone bromide, morphine sulfate/naltrexone, naltrexone, naltrexone HCL, naltrexone microsphere | | 11/23/2014 |
| Procedure Codes Related to Memory Gel Breast Implants Exploratory Analyses | | | 11/10/2014 |
| Buprenorphine Product Use Exploratory Analyses | | | 11/09/2014 |
| Opioid Medication Use Exploratory Analyses | Suboxone, Subutex, Buprenex, Butrans, generic oral buprenorphine, generic injectable buprenorphine, generic powder buprenorphine, opioid | | 11/09/2014 |
| CPAX Aneurysm Procedure Codes Exploratory Analyses | | CPAX aneurysm , emboli detection , intravenous microbubble injection , surgery of intracranial aneurysm , transcranial doppler study | 10/21/2014 |
| Lap-band Diagnosis Codes Exploratory Analyses | | | 10/20/2014 |
| Activa Tremor Control Procedures Exploratory Analyses | | | 10/16/2014 |
| Ascension Metacarpophalangeal Diagnoses Exploratory Analyses | | Ascension metacarpophalangeal (MCP) , arthritis , diffuse disease of connective tissue , osteoarthritis , sprain and strain of metacarpophalangeal of hand , traumatic arthropathy | 10/16/2014 |
| Ascension Metacarpophalangeal Procedures Exploratory Analyses | | arthroplasty metacarpophalangeal interphalangeal joint , arthrotomy for removal of prosthesis , division of joint | 10/16/2014 |
| CPAX Aneurysm Diagnoses Exploratory Analyses | | CPAX aneurysm , aneurysm , arthropod-borne hemorrhagic fever , cerebral aneurysm nonruptured , intracerebral hemorrhage (ICH) , mosquito-borne viral encephalitis , subarcahnoid hemorrhage | 10/16/2014 |
| Activa Tremor Control Diagnoses Exploratory Analyses | | Activa Tremor Control , essential tremor , other specified forms of tremor , paralysis agitans | 10/15/2014 |
| Dialysis HCPCS Procedure Codes Exploratory Analyses | | | 10/14/2014 |
| Dialysis ICD9 Diagnosis Codes Exploratory Analyses | | | 10/13/2014 |
| Dialysis ICD9 Procedure Codes Exploratory Analyses | | | 10/13/2014 |
| Gastrointestinal Therapy Agents Use 2 Exploratory Analyses | | | 09/23/2014 |
| Antiepileptic Drugs (AEDs) and Kidney Stones 2 Exploratory Analyses | anti-epileptic drug (AED), topiramate, gabapentin, zonisamide, lamotrigine, levetiracetam, carbamazepine, oxcarbazepine, phenytoin, valproic acid | | 09/23/2014 |
| Infectious Disease Diagnoses Exploratory Analyses | | Chagas disease , anthrax , ascariasis , hepatitis , hepatitis C , hookworm , influenza , leishmaniasis , malaria , methicillin-resistant Staphylococcus aureus (MRSA) , plague , schistosomiasis , trichuriasis , tuberculosis (TB) , tularemia | 09/23/2014 |
| Anti-Infective Agents Use 2 Exploratory Analyses | | | 09/23/2014 |
| Cardiovascular Therapy Agent Use 2 Exploratory Analyses | | | 09/23/2014 |
| Occurrence of Selected Generic Drugs 12 Exploratory Analyses | | | 09/22/2014 |
| Analgesic Use 3 Exploratory Analyses | | | 08/12/2014 |
| Diabetes Diagnoses and Occurrence of Laboratory Results Exploratory Analyses | | | 06/12/2014 |
| Anti-D, Dexamethasone, Prednisone, Romiplostim and Hemolysis Exploratory Analyses | | | 06/10/2014 |
| Immune Globulin Use Exploratory Analyses | | | 06/05/2014 |
| Injection Gammagard Use Exploratory Analyses | | | 06/04/2014 |
| Hemorrhagic Disorder Diagnoses Exploratory Analyses | | | 06/04/2014 |
| Occurrence of Kidney Stones Exploratory Analyses | | | 02/25/2014 |
| Hemodialysis Procedures Exploratory Analyses | | | 01/12/2014 |
| Enoxaparin Sodium Use Exploratory Analyses | | | 01/12/2014 |
| Injection Enoxaparin Sodium Use Exploratory Analyses | | | 01/12/2014 |
| Acute Kidney Failure Diagnoses Exploratory Analyses | | | 01/11/2014 |
| Occurrence of Selected Dental HCPCS Codes Exploratory Analyses | | | 01/11/2014 |
| Nursing Home Facility HCPCS Codes Exploratory Analyses | | | 01/10/2014 |
| Long Acting Beta2-Agonists (LABA) Policies and Drug Utilization Patterns Exploratory Analyses | | | 01/09/2014 |
| Prevalent and Incident Use of Acetazolamide Exploratory Analyses | | | 01/09/2014 |
| Prevalent and Incident Use of Quinine Sulfate Exploratory Analyses | | | 01/08/2014 |
| Quinine Sulfate, Diltiazem and Selected Thrombotic Events Exploratory Analyses | | hemolytic-uremic syndrome , immune thrombocytopenic purpura , other secondary thrombocytopenia , thrombotic microangiopathy , unspecified thrombocytopenia | 01/08/2014 |
| Anti-Seizure Medication Use Exploratory Analyses | topiramate, phentermine HCl, phentermine resin, carbamazepine, felbamate, tiagabine HCL, levetiracetam, lamotrigine, pregabalin, gabapentin, phenytoin, phenytoin sodium, phenytoin sodium extended, oxcarbazepine, valproic acid, zonisamide, ethosuxamide | | 01/08/2014 |
| Occurrence of Selected Generic Drugs 11 Exploratory Analyses | eltrombopag olamine, vigabatrin, telaprevir, rivaroxaban, febuxostat, benzyl alcohol, pitavastatin calcium, boceprevir, Pradaxa, dabigatran etexilate mesylate | | 01/08/2014 |
| Multiple Sclerosis Medication Use Exploratory Analyses | fingolimod HCL, glatiramer acetate, mitoxantrone HCL, interferon beta-1A, interferon beta-1A/albumin, natalizumab, interferon beta-1B | | 01/08/2014 |
| Multiple Sclerosis Medication Injections Exploratory Analyses | injection natalizumab, injection glatiramer acetate, injection interferon beta-1B, injection mitoxantrone HCL, injection interferon beta-1A, injection interferon beta-1A | | 01/08/2014 |
| Antiepileptic Drugs (AEDs) and Kidney Stones Exploratory Analyses | topiramate, carbamazepine, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenytoin, zonisamide, anti-epileptic drug (AED) | | 01/07/2014 |
| Chronic Kidney Disease Diagnoses Exploratory Analyses | | | 12/29/2013 |
| Nursing Home HCPCS Codes Exploratory Analyses | | | 12/29/2013 |
| Oral Antifungal Use Exploratory Analyses | | | 11/20/2013 |
| Occurrence of Selected Generic Drugs 10 Exploratory Analyses | | | 11/20/2013 |
| Antiepileptic Drug Use Exploratory Analyses | acetazolamide, carbamazepine, clobazam, clonazepam, diazepam, ethosuxamide, ezogabine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide, tiagabine, topiramate, valproic acid, vigabatrin, zonisamide | | 11/20/2013 |
| Bupropion HCL Sustained Release HCPCS Codes Exploratory Analyses | | | 10/07/2013 |
| Propylthiouracil and Methimazole Use 2 Exploratory Analyses | | | 10/07/2013 |
| Unspecified Anterior Pituitary Hyperfunction and Hypertrophy of the Breast Diagnoses Exploratory Analyses | | | 10/07/2013 |
| Occurrence of Selected Generic Drugs 9 Exploratory Analyses | warfarin sodium, valproic acid, ribavirin, ribavirin/interferon alfa-2B, paroxetine HCL, paroxetine mesylate, mycophenolate mofetil, mycophenolate sodium, methotrexate, methotrexate sodium, ezetimibe/simvastatin, niacin/simvastatin, simvastatin, lisinopril, lisinopril/dietary sup. Cmb10, lisinopril/hydrochlorothiazide | | 10/07/2013 |
| HIV and HBV Infection Diagnoses Exploratory Analyses | | | 10/07/2013 |
| Analgesic Use 2 Exploratory Analyses | acetaminophen with codeine, codeine sulfate, codeine phosphate, aspirin/codeine phosphate, fentanyl citrate, methadone HCL, morphine sulfate, oxycodone HCL, oxymorphone HCL, sulindac, tramadol HCL | | 09/14/2013 |
| Anti-Infective Agents Use Exploratory Analyses | acyclovir, acyclovir sodium, atovaquone, doxycycline calcium, doxycline hyclate, nitazoxanide, norfloxacin, telithromycin, tenofovir disoproxil fumarate | | 09/14/2013 |
| Cardiovascular Therapy Agents Use Exploratory Analyses | acebutolol HCL, aliskiren hemifumarate, amlodipine besylate, ambrisentan, atenolol, betaxolol HCL, bosentan, captopril, carvedilol, conivaptan HCL, diltiazem HCL, eprosartan mesylate, indapamide, labetalol HCL, lisinopril, metoprolol succinate, metoprolol tartrate, metoprolol/hydrochlorothiazide, nadolol, nimodipine, perindopril erbumine, propafenone HCL, trandolapril, triamterene | | 09/14/2013 |
| Gastrointestinal Therapy Agents Use Exploratory Analyses | aprepitant, fosaprepitant dimeglumine, cimetidine, dexlansoprazole, dicyclomine HCL, lubiprostone, mesalamine, nizatidine, sucralfate | | 09/13/2013 |
| Occurrence of Selected Generic Drugs 7 Exploratory Analyses | solifenacin succinate, cyclosporine modified, cyclosporine, albuterol, alvimopan, chlorambucil, tretinoin, vorinostat, lindane, calcium acetate, phytonadione, albuterol sulfate, levalbuterol tartrate, levalbuterol HCL | | 07/17/2013 |
| Occurrence of Selected Generic Drugs 8 Exploratory Analyses | ambrisentan, bosentan, isotretinoin, lenalidomide, thalidomide, buprenorphine HCL, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, alvimopan, varenicline tartrate, propoxyphene HCL, alosetron HCL, sibutramine HCL, metoclopramide HCL, nilotinib HCL, bupropion HCL, sacrosidase, propoxyphene HCL/acetaminophen, propoxyphene HCL/ASA/caffeine, ribavirin/interferon alfa-2B, naloxone HCL | | 07/17/2013 |
| Parkinson’s Disease Medication Use Exploratory Analyses | | | 06/07/2013 |
| Oxicam NSAIDs, Modafinil/Armodafinil, Sulfamothoxazole and Severe Cutaneous Adverse Reaction (SCAR) Events Exploratory Analyses | | | 06/07/2013 |
| Angiotensin Receptor Blockers (ARBs), Hydrochlorothiazide, Atenolol, Amlodipine Use and Celiac Disease Exploratory Analyses | angiotensin II receptor blocker (ARB), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan, hydrochlorothiazide (HCTZ), atenolol, amlodipine | | 06/07/2013 |
| Occurrence of Selected Pediatric Drugs 1 Exploratory Analyses | | | 06/07/2013 |
| Vascular Endothelial Growth Factor (VEGF) Inhibitor Prevalent and Incident Use Exploratory Analyses | | | 05/09/2013 |
| Dabigatran, Rivaroxaban, and Warfarin Use Exploratory Analyses | | | 05/03/2013 |
| Dabigatran, Warfarin and GI Bleed, Intracerebral Hemorrhage Exploratory Analyses | | | 05/03/2013 |
| Warfarin and GI Bleed, Intracerebral Hemorrhage Exploratory Analyses | | | 05/03/2013 |
| Dabigatran (Pradaxa), Warfarin and GI Bleed, Intracerebral Hemorrhage Safety Analyses | | | 02/11/2013 |
| Lindane Use Modular Program Exploratory Analyses | | | 01/10/2013 |
| Natalizumab, Efalizumab, and Progressive Multifocal Leukoencephalopathy (PML) Exploratory Analyses | | | 01/10/2013 |
| Selgiline Use Exploratory Analyses | | | 01/10/2013 |
| Bupropion and Naltrexone Use 2 Exploratory Analyses | | | 01/09/2013 |
| Bupropion and Naltrexone Use 1 Exploratory Analyses | | | 01/09/2013 |
| Duloxetine, Pregabalin, and Milnacipran Use 1 Exploratory Analyses | | | 01/09/2013 |
| Duloxetine, Pregabalin, and Milnacipran Use 2 Exploratory Analyses | | | 01/09/2013 |
| Clopidogrel and Prasugrel Use Exploratory Analyses | | | 01/09/2013 |
| Injection Amphotericin Procedures Exploratory Analyses | injection amphotericin B, injection amphotericin B lipid form, injection amphotericin B lipid complex, injection amphotericin B cholesteryl, injection amphotericin B liposome | | 01/07/2013 |
| Hip Implant Procedures and Diagnoses 2 Exploratory Analyses | | acetabular component , acquired hemophilia , femoral component , mechanical complication of internal orthopedic device implant and graft , partial hip replacement , total hip replacement | 01/07/2013 |
| Occurrence of Selected Generic Drugs 6 Exploratory Analyses | zidovudine, stavudine, didanosine, lamivudine, emtricitabine, abacavir sulfate, entecavir, tenofovir disoproxil fumarate, emtricitabine/tenofovir, efavirenz/emtricitab/tenofovir, didanosine/calcium carb/mag, didanosine/sodium citrate | | 01/07/2013 |
| Nucleoside Reverse Transcriptase Inhibitor Procedures Exploratory Analyses | | | 01/07/2013 |
| Amphotericin Use Exploratory Analyses | | | 01/07/2013 |
| Isoniazid Use Exploratory Analyses | | | 01/07/2013 |
| Boceprevir and Telaprevir Use Exploratory Analyses | | | 01/07/2013 |
| Occurrence of Selected Generic Drugs 4 Exploratory Analyses | | | 12/13/2012 |
| Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Quarter) Exploratory Analyses | | | 12/13/2012 |
| Occurrence of Selected Generic Drugs 5 Exploratory Analyses | ambrisentan, bosentan, buprenorphine HCL, eltrombopag olamine, fentanyl, hydromorphone HCL, isotretinoin, lenalidomide, mifepristone, oxycodone HCL, romiplostim, rosiglitazone maleate, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, thalidomide, vigabatrin, alosetron HCL | | 12/13/2012 |
| Natalizumab and Efalizumab Use Exploratory Analyses | | | 12/13/2012 |
| Occurrence of Selected Generic Drugs 3 Exploratory Analyses | ambrisentan, bosentan, buprenorphine HCL, fentanyl, hydromorphone HCL, isotretinoin, lenalidomide, methadone HCL, morphine sulfate, oxycodone HCL, rosiglitazone maleate, rosiglitazone/glimepiride, rosiglitazone/metformin HCL, thalidomide, alosetron HCL, naloxone HCL | | 12/13/2012 |
| Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Year) Exploratory Analyses | | | 12/13/2012 |
| Injection Ustekinumab and Injection Denosumab Procedures Exploratory Analyses | | | 12/13/2012 |
| Injection Natalizumab Procedures Exploratory Analyses | | | 12/13/2012 |
| Drugs that Act on the Renin-Angiotensin-Aldosterone System (Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Aliskiren) and Angioedema Safety Analyses | | | 10/19/2012 |
| Occurrence of Selected Generic Drugs 1 Exploratory Analyses | azathioprine, azathioprine sodium, benzonatate, cabergoline, everolimus, lopinavir/ritonavir, mercaptopurine, ralegravir potassium, ribavirin, ribavirin A-2B, tolvaptan, voriconazole, tenofovir disoproxil fumarate | | 08/30/2012 |
| Occurrence of Selected HCPCS Codes 1 Exploratory Analyses | combination peginterferon and ribavirin, cabergoline oral, mercaptopurine oral, negative pressure wound therapy (NPWT) | | 08/30/2012 |
| Propylthiouracil and Methimazole Use Exploratory Analyses | | | 08/02/2012 |
| Occurrence of Selected Generic Drugs 2 Exploratory Analyses | ambrisentan, bosentan, dronedarone, lisinopril, acitretin/emollient combo. 26, isotretinoin, methimazole, methotrexate, methotrexate sodium, clarithromycin, fluconazole, telavancin, busulfan, chlorambucil, cyclophosphamide, lenalidomide, thalidomide, trastuzumab, topiramate, valproic acid, lithium carbonate, lithium citrate, finasteride, lisinopril/hydrochlorothiazide, warfarin, acitretin | | 08/02/2012 |
| Occurrence of Selected HCPCS Codes 2 Exploratory Analyses | | | 08/02/2012 |
| Infliximab Use Exploratory Analyses | | | 08/02/2012 |
| Injection Infliximab Procedures Exploratory Analyses | | | 08/02/2012 |
| Analgesics Use Exploratory Analyses | | | 08/02/2012 |
| Dalfampridine Use Exploratory Analyses | | | 08/02/2012 |
| Lindane Use Summary Table Exploratory Analyses | | | 06/22/2012 |
| Regional Enteritis and Ulcerative Enterocolitis Diagnoses Exploratory Analyses | | | 06/22/2012 |
| Arthritis Diagnoses Exploratory Analyses | | Felty's syndrome , arthritis , inflammatory polyarthropathy , juvenile chronic polyarthritis , rheumatoid arthritis | 06/22/2012 |
| Clozapine Use Exploratory Analyses | | | 06/19/2012 |
| Use of Vascular Endothelial Growth Factor (VEGF) Inhibitors Exploratory Analyses | vascular endothelial growth factor (VEGF) inhibitor, bevacizumab, sorafenib tosylate, sunitinib malate, thalidomide | | 06/19/2012 |
| Bone Resorption Inhibitor Use (by Drug Class) Exploratory Analyses | | | 06/19/2012 |
| VEGF and Bone Resorption Inhibitor Procedures Exploratory Analyses | | | 06/19/2012 |
| Negative Pressure Wound Therapy (NPWT) Procedures Exploratory Analyses | | | 06/08/2012 |
| Milk Allergy Diagnoses Exploratory Analyses | | | 05/11/2012 |
| Hip Implant Procedures and Diagnoses Exploratory Analyses | | | 05/11/2012 |
| Progressive Multifocal Leukoencephalopathy Diagnoses Exploratory Analyses | | | 04/26/2012 |
| Hyperlipidemia Diagnoses Exploratory Analyses | | | 04/26/2012 |
| Heart/Lung Resuscitation (CPR), Injection Diphenhydramine Hydrochloride (HCL), Injection Adrenaline Epinephrine Procedures Exploratory Analyses | | | 04/26/2012 |
| Unspecified Allergic Reaction Diagnoses Exploratory Analyses | | | 04/26/2012 |
| Cardiopulmonary Resuscitation (CPR) Not Otherwise Specified Procedures Exploratory Analyses | | | 04/26/2012 |
| Asthma Diagnoses Exploratory Analyses | | | 04/26/2012 |
| Acute Myocardial Infarction Diagnoses Exploratory Analyses | | | 04/25/2012 |
| Serious Cutaneous Adverse Reaction (SCAR) Diagnoses Exploratory Analyses | | | 04/09/2012 |
| Aseptic Necrosis of Bone Jaw Diagnoses Exploratory Analyses | | | 04/09/2012 |
| Angiotensin II Receptor Blockers and Celiac Disease Exploratory Analyses | angiotensin II receptor blocker (ARB), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan | | 01/16/2012 |
| Smoking Cessation Drugs and Cardiovascular Outcomes Safety Analyses | | acute coronary occlusion without myocardial infarction , acute myocardial infarction (AMI) , cardiovascular outcome , intermediate coronary syndrome , unstable angina | 01/15/2012 |
